Insulin Delivery Devices Market Analysis

Explore In-Depth Insulin Delivery Devices Market Analysis, Covering Detailed Segmentation and Geographical Insights for the Period of 2019 to 2030

Report Code: 10326
Pages: 290

Type Analysis

With a share of around 50% in 2024, insulin pens dominate the insulin delivery devices market. This can be attributed to the increasing prevalence of diabetes and the surging focus of insulin pen manufacturers on increasing their presence in countries with a large number of diabetic patients, such as China and India. Furthermore, the technological advancements in the pens and the medical reimbursements offered in developed regions are driving the growth of the market in this category.

Further, the reusable pens bifurcation holds the larger share, and it is expected to maintain the same trend during the forecast period. This can be attributed to the user-friendly design of reusable pens, which helps minimize dosage error.

We have studied the following types:

Insulin Pens (Largest and Fastest-Growing Category)
- Reusable (Larger Subcategory)
- Disposable (Faster-Growing Subcategory)
Insulin Pumps
- External/Tethered
- Patch
Insulin Syringes

Distribution Channel Analysis

Pharmacies will dominate the insulin delivery devices market in 2024 with 55% revenue share. The high sales of these devices via this channel are mainly because patients suffering from diabetes prefer to purchase these devices from pharmacies.

The e-commerce category is expected to witness the highest CAGR, of 11.5%, during the forecast period, mainly due to the fact that online pharmacies offer convenience to consumers. They enable people to compare similar products, play electronically, have the products delivered at their doorstep, and avail of discounts and promotional offers.

Insulin Delivery Devices Market Segments

The following distribution channels have been analyzed:

Pharmacies (Largest Category)
Diabetes Clinics/Centers
E-Commerce (Fastest-Growing Category)

End Use Analysis

The home-use category accounts for the largest share in the market, in 2024. This is due to the surging prevalence of diabetes, rising awareness about diabetes management, and increasing geriatric population. Moreover, the growing obese population has been leading to a higher number of cases of diabetes, which further supports the market growth in this category.

The report offers insights for the following end uses:

Home Use (Largest Category)
Hospitals (Fastest-Growing Category)
Others

Regional Analysis

North America Holds Largest Share in Market

Globally, North America is the largest market for these devices, contributing around 40% revenue in 2024.
The regional market is growing mainly due to the surging prevalence of lifestyle diseases, including diabetes and obesity, rising knowledge of people on newer, more-advanced ways of diabetes management, and increasing healthcare spending.
Moreover, the growing obese population has been leading to a large number of diabetes cases in the region.
Obesity and insulin resistance have been considered as independent risk factors for diabetes; thus, the rising obese population is driving the demand for these devices in the region.
Furthermore, several awareness programs with respect to this common endocrine disorder in North America are promoting diabetes care among citizens, which will further propel the market growth in the coming years.
It has also been observed that the increasing prevalence of diabetes poses an economic burden and escalates the healthcare spending.
For instance, as per the American Diabetes Association (ADA), the economic burden of diabetes and prediabetes is USD 322 billion each year, and the healthcare cost for a diabetic patient is 2.3 times higher than for someone without this condition.
Thus, the need to curb the healthcare burden requires extensive care, which is expected to boost the growth of the market in the coming years.
APAC will witness the highest CAGR in the forecast period, of 11.2%.
This growth is mainly led by the growing geriatric population, increasing prevalence of diabetes, and unhealthy lifestyle choices due to rapid urbanization.
The number of elderly people in APAC is increasing at an unprecedented rate, and the region is at the forefront of the global population aging crisis. According to the United Nations Population Fund (UNFPA), by 2050, one in every four people in Asia and the Pacific will be over 60 years of age.
Between 2010 and 2050, the region's population of older people (those over the age of 60 years) will triple, reaching nearly 1.3 billion.
Additionally, China, India, and Japan are the leading countries in the APAC region in terms of the older population.

Insulin Delivery Devices Market Regional Analysis

The following regions and countries are covered in the report:

North America (Largest Regional Market)
- U.S. (Larger and Faster-Growing Regional Market)
- Canada
Europe
- Germany (Largest and Fastest-Growing Regional Market)
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia-Pacific (APAC) (Fastest-Growing Regional Market)
- China (Largest and Fastest-Growing Regional Market)
- Japan
- India
- Rest of APAC
Latin America (LATAM)
- Brazil (Largest Country Market)
- Mexico (Fastest-Growing Country Market)
- Rest of LATAM
Middle East and Africa (MEA)
- Saudi Arabia (Fastest-Growing Country Market)
- South Africa (Largest Country Market)
- U.A.E.
- Rest of MEA